Source:http://linkedlifedata.com/resource/pubmed/id/10810988
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2000-7-19
|
pubmed:abstractText |
Eighty-nine canine mammary tumors and dysplasias of 66 bitches were investigated to determine the immunohistochemical expression of classical estrogen receptor (ER-alpha) and its clinical and pathologic associations and prognostic value. A complete clinical examination was performed and reproductive history was evaluated. After surgery, all animals were followed-up for 18 months, with clinical examinations every 3-4 months. ER-alpha expression was higher in tumors of genitally intact and young bitches (P < 0.01, P < 0.01) and in animals with regular estrous periods (P = 0.03). Malignant tumors of the bitches with a previous clinical history of pseudopregnancy expressed significantly more ER-alpha (P = 0.04). Immunoexpression of ER-alpha decreased significantly with tumor size (P = 0.05) and skin ulceration (P = 0.01). Low levels of ER-alpha were significantly associated with lymph node involvement (P < 0.01). Malignant tumors had lower ER-alpha expression than did benign tumors (P < 0.01). Proliferation index measured by proliferating cell nuclear antigen immunostaining was inversely correlated with ER-alpha scores (P = 0.05) in all tumors. Low ER-alpha levels in primary malignant tumors were significantly associated with the occurrence of metastases in the follow-up (P = 0.03). Multivariate analyses were performed to determine the prognostic significance of some follow-up variables. ER-alpha value, Ki-67 index, and age were independent factors that could predict disease-free survival. Lymph node status, age, and ER-alpha index were independent prognostic factors for the overall survival. The immunohistochemical detection of ER-alpha in canine mammary tumors is a simple technique with prognostic value that could be useful in selecting appropriate hormonal therapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0300-9858
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
37
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
239-47
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10810988-Animals,
pubmed-meshheading:10810988-Castration,
pubmed-meshheading:10810988-Dog Diseases,
pubmed-meshheading:10810988-Dogs,
pubmed-meshheading:10810988-Estrogen Receptor alpha,
pubmed-meshheading:10810988-Female,
pubmed-meshheading:10810988-Follow-Up Studies,
pubmed-meshheading:10810988-Ki-67 Antigen,
pubmed-meshheading:10810988-Mammary Neoplasms, Animal,
pubmed-meshheading:10810988-Prognosis,
pubmed-meshheading:10810988-Receptors, Estrogen
|
pubmed:year |
2000
|
pubmed:articleTitle |
Immunohistologic detection of estrogen receptor alpha in canine mammary tumors: clinical and pathologic associations and prognostic significance.
|
pubmed:affiliation |
Department of Animal Pathology II, Veterinary School, Universidad Complutense de Madrid, Spain. ananieto@eucmax.sim.ucm.es
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|